SCHEMBL29566672

SCHEMBL29566672

O=S(=O)(Nc1nc(Oc2ccccc2)cc(-c2ccccc2)n1)c1cccc(N2CCC(F)(F)CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ MAPT P10636 2/20 0.37
▸ KIF18A Q8NI77 5/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ HRH1 P35367 3/20 0.34
▸ HRH4 Q9H3N8 3/20 0.34
▸ GPR39 O43194 1/20 0.34
▸ HRH2 P25021 1/20 0.34
▸ HRH3 Q9Y5N1 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ MMP8 P22894 1/20 0.34
▸ MMP13 P45452 1/20 0.34
▸ LOXL2 Q9Y4K0 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ SCN10A Q9Y5Y9 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310192 1.00 MAPK1 (0.39) MAPK1TDP1MAPTKIF18AALDH1A1
SCHEMBL24310196 0.81 TDP1 (0.40) MAPK1TDP1MAPTALDH1A1HRH1
SCHEMBL29566739 0.79 MAPK1 (0.48) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL24310193 0.79 MAPK1 (0.48) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812723 0.77 MAPT (0.50) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812951 0.76 MAPK1 (0.47) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812838 0.76 MAPK1 (0.46) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26813002 0.75 GPR39 (0.53) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26806813 0.73 MAPT (0.61) MAPK1TDP1MAPTALDH1A1GPR39
SCHEMBL26812825 0.72 TDP1 (0.51) MAPK1TDP1MAPTALDH1A1GPR39

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback